论文部分内容阅读
目的研究小梁切除与青光眼引流器植入对青光眼的治疗价值。方法选取我院2010年7月至2013年4月48例(50眼)患者作为研究对象,随机分为实验组和对照组各24例,对照组接受小梁切除治疗青光眼,实验组进行青光眼引流器植入治疗青光眼,比较2组治疗后1周的视力、眼压和并发症。结果两组患者治疗后眼压和视力均有改善,实验组改善情况明显优于对照组,且实验组并发症发生率低于对照组,统计学具有意义(P<0.05)。结论青光眼引流器植入可有效地降低眼压,减少术后并发症,提高患者视力,治疗效果显著,值得在临床上推广。
Objective To study the therapeutic value of trabeculectomy and glaucoma drainage device implantation in glaucoma. Methods Forty-eight patients (50 eyes) from July 2010 to April 2013 in our hospital were randomly divided into experimental group (24 cases) and control group (24 cases). The control group received trabeculectomy for glaucoma. The experimental group received glaucoma drainage Implantation treatment of glaucoma, visual acuity, intraocular pressure and complications in two groups after 1 week of treatment were compared. Results After treatment, IOP and visual acuity improved in both groups. The improvement in experimental group was better than that in control group, and the complication rate in experimental group was lower than that in control group (P <0.05). Conclusion Glaucoma drainage device can effectively reduce intraocular pressure, reduce postoperative complications and improve visual acuity in patients with significant therapeutic effect, which is worth to be popularized clinically.